Combined inhibition of CDK2 and CDK4/6 overcomes acquired resistance to CDK4/6 inhibitors in breast cancer via RB-independent pathway

被引：1
|
作者：
Pandey, Kamal [1 ]
机构：
[1] CHA Univ, Seongnam Si, South Korea
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
CDK4/6; hormone receptor-positive breast cancer; drug resistance;
D O I：
10.1158/1538-7445.AM2020-5811
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5811
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Inhibition of CDK2 overcomes primary and acquired resistance to CDK4/6 inhibitors
    Hall, Claire R.
    Bisi, John E.
    Strum, Jay C.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [2] Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer
    Abeer J. Al-Qasem
    Carla L. Alves
    Sidse Ehmsen
    Martina Tuttolomondo
    Mikkel G. Terp
    Lene E. Johansen
    Henriette Vever
    Luna V. A. Hoeg
    Daniel Elias
    Martin Bak
    Henrik J. Ditzel
    [J]. npj Precision Oncology, 6
  • [3] Combined CDK2 and CDK4/6 Inhibition Overcomes Palbociclib Resistance in Breast Cancer by Enhancing Senescence
    Pandey, Kamal
    Park, Nahee
    Park, Kyung-Soon
    Hur, Jin
    Cho, Yong Bin
    Kang, Minsil
    An, Hee-Jung
    Kim, Sewha
    Hwang, Sohyun
    Moon, Yong Wha
    [J]. CANCERS, 2020, 12 (12) : 1 - 17
  • [4] Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer
    Al-Qasem, Abeer J.
    Alves, Carla L.
    Ehmsen, Sidse
    Tuttolomondo, Martina
    Terp, Mikkel G.
    Johansen, Lene E.
    Vever, Henriette
    Hoeg, Luna V. A.
    Elias, Daniel
    Bak, Martin
    Ditzel, Henrik J.
    [J]. NPJ PRECISION ONCOLOGY, 2022, 6 (01)
  • [5] RB-independent activity of Cdk4/6 in bladder cancer
    Castellano, Daniel E.
    Rubio, Carolina
    Lopez-Calderon, Fernando
    Segovia, Cristina
    Porto, Marta Duenas
    Martinez-Fernandez, Monica
    Otero, Irene
    Manneh, Ray
    Sepulveda, Juan Manuel
    Villacampa, Felipe
    Paramio, Jesus
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] CDK2 and CDK4/6 inhibition in GIST: Mechanisms of response and resistance
    Schaefer, Inga-Marie
    Hemming, Matthew L.
    Lundberg, Meijun Z.
    Serrata, Matthew P.
    Goldaracena, Isabel
    Liu, Ninning
    Yin, Peng
    Paulo, Joao A.
    Gygi, Steven P.
    George, Suzanne
    Morgan, Jeffrey A.
    Bertagnolli, Monica M.
    Sicinska, Ewa T.
    Marino-Enriquez, Adrian
    Hornick, Jason L.
    Raut, Chandrajit P.
    Demetri, George D.
    Ou, Wen-Bin
    Saka, Sinem K.
    Fletcher, Jonathan A.
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (18)
  • [7] Response and resistance to CDK2 and CDK4/6 inhibition in GIST.
    Schaefer, Inga-Marie
    Lundberg, Meijun Z.
    Hemming, Matthew L.
    Saka, Sinem K.
    Serrata, Matthew P.
    Goldaracena, Isabel
    Liu, Ninning
    Yin, Peng
    Paulo, Joao A.
    Gygi, Steven
    Demetri, George D.
    Sicinska, Ewa
    Marino-Enriquez, Adrian
    Hornick, Jason L.
    Raut, Chandrajit P.
    Ou, Wen-Bin
    Fletcher, Jonathan A.
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [8] CDK4/6 inhibitors in breast cancer
    Dukelow, Tim
    Kishan, Divya
    Khasraw, Mustafa
    Murphy, Conleth G.
    [J]. ANTI-CANCER DRUGS, 2015, 26 (08) : 797 - 806
  • [9] CDK6 overexpression promotes resistance to CDK4/6 inhibitors in breast cancer
    Li, Qing
    Razavi, Pedram
    Li, Zhiqiang
    Paula, Arnaud F. Da Cruz
    Brogi, Edi
    Scaltriti, Maurizio
    Reis-Filho, Jorge S.
    Chandarlapaty, Sarat
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [10] IMMUNOLOGICAL MECHANISMS OF RESISTANCE TO CDK4/CDK6 INHIBITORS IN BREAST CANCER
    Petroni, Giulia
    Gouin, Kenneth
    Martinez, Aitziber Buque
    Knott, Simon
    Formenti, Silvia
    Galluzzi, Lorenzo
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A763 - A763
12345